Analystreport

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $24.00 to $5.00.

Galmed Pharmaceuticals Ltd. - Ordinary Shares  (GLMD) 
Last galmed pharmaceuticals ltd. - ordinary shares earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: galmedpharma.investorroom.com